register

Leadership & Management

Rising trade-offs and trust fractures: Novartis President decodes shifting rules of leadership

Health Industry Hub | May 25, 2026 |

As pressure builds across policy, innovation and public expectation, Ali Rossiter, Country President, Novartis ANZ, joins the Health Industry Hub senior leadership podcast series to unpack what leadership demands when certainty itself has become unstable.

Drawing on more than two decades of global leadership experience across diagnostics, ASX-listed healthcare and now multinational pharmaceuticals, Rossiter reflects on the forces reshaping leadership far beyond the walls of any one organisation. Framed by the University of Sydney leadership researchers, the discussion explores a ‘decade of disorientation defined by overlapping disruptions and messy shifts that leave leaders navigating constant ambiguity.

As debates intensify around Health Technology Assessment (HTA) reform and Most Favoured Nation (MFN) pricing policy, Rossiter examines the growing perception that corporations are extracting more value than they create, and how organisations like Novartis are being challenged to respond in environments where government, industry, clinicians and patients rarely move in perfect alignment.

The conversation also turns inward, examining the changing fabric of work itself. As employee expectations fragment across generations, values and definitions of purpose, Rossiter reflects on what organisational cohesion looks like when leaders can no longer assume a shared understanding of work, workplaces and leadership. In sharing advice for the next generation of senior leaders, Rossiter speaks to the challenge of leading through ambiguity without becoming consumed by it.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

New funding to bring global CAR-T trials to young cancer patients

New funding to bring global CAR-T trials to young cancer patients

Health Industry Hub | September 14, 2026 |

The government is delivering the first investment under the $300 million MRFF Australian Cancer Research Program (ACRP), to bring international […]

More


News - Pharmaceuticals

Rising gynae cancers meets a system forcing patients to pay the price

Rising gynae cancers meets a system forcing patients to pay the price

Health Industry Hub | September 14, 2026 |

Sector leaders, government and women with lived experience unite in Canberra today to accelerate evidence-based action, as gynaecological cancer diagnoses […]

More


News - MedTech & Diagnostics

Analysis confirms private health insurance cuts targets vulnerable pensioners

Analysis confirms private health insurance cuts target vulnerable pensioners

Health Industry Hub | September 14, 2026 |

New analysis by the Parliamentary Budget Office (PBO) shows that half of the $3 billion dollars the Albanese Government expects […]

More


News - MedTech & Diagnostics

Chalmers retreats as startup tax backlash forces further changes

Chalmers retreats as startup tax backlash forces further changes

Health Industry Hub | September 14, 2026 |

The Albanese Government has been forced to retreat from several of the most contentious elements of its proposed startup tax […]

More


This content is copyright protected. Please subscribe to gain access.